|
Oncology & Hematology
|
|
|
PHOENIX – Intensity-modulated radiotherapy is more expensive than 3-D–conformal radiotherapy is and has not been shown to improve standard outcomes in patients with head and neck cancer. But it results in better quality of life. These findings from two studies presented at the Multidisciplinary... »
Exemestane significantly decreases bone mineral density in healthy postmenopausal women who take it to reduce their risk of breast cancer, according to a study published online Feb. 7 in The Lancet Oncology. Two years of daily oral treatment with the steroidal aromatase inhibitor was found to... »
SAN FRANCISCO – Radium-223 chloride, the first alpha particle–emitting bone-targeted agent, is efficacious and safe for treating men with bone metastases of castration-resistant prostate cancer, according to a randomized, phase-III trial reported at the Genitourinary Cancers Symposium. The 809 men... »
Interested in being notified of new Oncology & Hematology news?
Click here to view our Oncology & Hematology RSS Feed.
| Feb 5 - 12 Departs Ft. Lauderdale, FL | Preventive Medicine |
| Feb 6 - 11 Dallas, TX | Society for Maternal-Fetal Medicine (SMFM): Annual Meeting (The Pregnancy Meeting) |
| Feb 6 - 10 Sarasota, FL | Rheumatology: Improving Primary Care Outcomes Through Diagnosis and Treatment |
| Feb 7 - 11 San Francisco, CA | American Academy of Orthopaedic Surgeons (AAOS): Annual Meeting |
| Feb 8 - 12 Naples, FL | Dermatology Foundation (DF): Clinical Symposia |
| Feb 8 - 11 Barcelona, | International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) |
| Feb 8 - 10 San Diego, CA | American Academy of Emergency Medicine (AAEM): Annual Scientific Assembly |
| Feb 9 - 11 New York, NY | Integrative Healthcare Symposium |
| Feb 9 - 11 New Orleans, LA | American Federation for Medical Research (AFMR): Southern Regional Meeting |
| Feb 12 - 15 Freiburg, | German Society for Thoracic and Cardiovascular Surgery: 41st Annual Meeting |